Yield10 Bioscience (NASDAQ:YTEN) Lifted to "Buy" at Zacks Investment Research
Yield10 Bioscience (NASDAQ:YTEN – Get Rating) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Friday, Zacks.com reports. The brokerage presently has a $3.00 price objective on the specialty chemicals company’s stock. Zacks Investment Research‘s target price would suggest a […]